[Anomalies of the masticatory apparatus in beta-thalassemia. The present status after transfusion and iron-chelating therapy].
Fifty-four homozygous beta-thalassemic patients (26 men and 28 women) aged 7 to 24 years, who had been treated with high transfusion regimen (Hb levels = 9-10 g/dl) and chelation therapy (desferrioxamine, 35-50 mg/kg), underwent clinical and radiographic investigations. This study was aimed at assessing the clinical and radiographic changes in the stomatognathic system (teeth, mandible and maxilla, occlusion relationship and dental bases). All patients underwent orthopantomography and teleradiography of the skull, in the lateral view. Twenty thalassemic patients (13 men and 7 women) of the same age but treated with low transfusion regimes (Hb levels = 5-6 g/dl) were examined as a control group. Our results indicate that: 1) in the control group, osteopenia is the specific lesion of anemia, in both the alveolar process and the mandible, following marrow expansion. Consequently, diastema of incisors and several types of malocclusion follow--i.e., overjet, anterior open-bite and crossbite, nearly all of them associated with II dental and skeletal patterns of Angle's classification. 2) In adequately transfused patients, no lesions are observed in 55% of cases, in both the teeth and the facial skeleton. This means that current treatment methods can prevent bone abnormalities, especially if transfusions begin at birth. Nevertheless, osteopenia of the mandible (31.4%) and dental and/or skeletal malocclusions (40.7%) remain in many cases, because of persistent marrow expansion, which usually follows incorrect treatment. 3) General dental diseases--e.g., caries, paradentosis, gingivitis, etc.--affect both populations with the same incidence.
Scutellari
P N
PN
Istituto di Radiologia, Università degli Studi di Ferrara.
Orzincolo
C
C
Andraghetti
D
D
Gamberini
M R
MR
D000293:Adolescent; D000328:Adult; D001803:Blood Transfusion; D002508:Cephalometry; D015913:Chelation Therapy; D002648:Child; D003131:Combined Modality Therapy; D003676:Deferoxamine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007501:Iron; D008297:Male; D011859:Radiography; D009057:Stomatognathic Diseases / Q000000981:diagnostic imaging* / Q000209:etiology / Q000628:therapy; D013284:Stomatognathic System / Q000000981:diagnostic imaging; D017086:beta-Thalassemia / Q000150:complications / Q000000981:diagnostic imaging* / Q000628:therapy
D007501:Iron; D003676:Deferoxamine
Anomalie dell'apparato masticatorio nella beta-talassemia. Stato attuale dopo terapia trasfusionale e chelante del ferro.